Key result
Pediatric congenital myopathies are linked to mostly preserved cognition but variable domain-specific deficits.
Why the study?
In congenital myopathies, cognitive, neuropsychological, and psychosocial outcomes remain poorly characterized.
Systematic Review (n=160)
Neuropsychological and psychosocial outcomes in pediatric congenital myopathies are heterogeneous and understudied, highlighting the need for standardized, motor-adapted assessments in multidisciplinary care.
Cognitive and QoL outcomes in pediatric congenital myopathies remain poorly characterized by mostly case reports; leaves open need for prospective studies.
Background: Congenital myopathies (CMs) are a heterogeneous group of rare or ultra-rare inherited muscular disorders in which cognitive, neuropsychological and psychosocial outcomes remain poorly characterized. Objective: To synthesize current evidence on cognitive development, neuropsychological and quality-of-life (QoL) outcomes in pediatric CMs, including caregiver burden. Methods: A systematic review was conducted according to PRISMA guidelines and registered on PROSPERO (CRD420261373780). PubMed, Scopus, Web of Science and ClinicalTrials.gov were searched up to June 2026. Observational studies reporting neuropsychological or psychosocial outcomes in children with CMs were included. Results: 18 studies (104 patients; 56 caregivers) were included, predominantly case reports/series (72.2%). Cognitive outcomes were heterogeneous: most patients showed preserved intellectual functioning; however, beyond the expected motor impairment, some exhibited additional language or domain-specific deficits. More severe profiles were observed in ACTA1-related disease and selected rare genotypes, often associated with brain abnormalities. In contrast, cognition was largely preserved in X-linked myotubular myopathy, although adaptive functioning and QoL were frequently reduced. School outcomes were rarely reported. Caregiver data indicated a substantial and multidimensional burden. Conclusion: Neuropsychological and psychosocial outcomes in pediatric CMs are clinically relevant but understudied and heterogeneous across genotypes. Standardized, motor-adapted assessment should be integrated into multidisciplinary care. QoL evidence remains limited to XLMTM and SELENON-related myopathy. Prospective, genotype-stratified studies including longitudinal, academic, adaptive and caregiver outcomes are needed, particularly alongside emerging disease-modifying therapies. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261373780, identifier CRD420261373780.
No takes yet. Share an insight, caveat, or question.
Rinella et al. (2026) conducted a systematic review in Congenital myopathies (n=160). Congenital myopathy was evaluated on Neuropsychological functioning, cognitive development, and quality of life. Pediatric congenital myopathies are associated with heterogeneous cognitive outcomes, with most patients showing preserved intellectual functioning but some exhibiting language or domain-specific deficits, alongside substantial caregiver burden.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: